Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
EMBO Journal is Scopus-indexed (Q1, CiteScore 13.6), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 0261-4189Verify ISSN ↗1460-2075Verify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Microbiology (all) | 3 / 63 | 96th | Q1 |
| Neuroscience (all) | 8 / 112 | 93rd | Q1 |
| Biochemistry, Genetics and Molecular Biology (all) | 17 / 223 | 92nd | Q1 |
| Molecular Biology | 41 / 414 | 90th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 1982–present, best quartile Q1, CiteScore 13.6.
EMBO Journal is Q1 in Immunology and Microbiology (all) (rank 3 of 63), Q1 in Neuroscience (all) (rank 8 of 112) and Q1 in Biochemistry, Genetics and Molecular Biology (all) (rank 17 of 223), by CiteScore 2025. It is ranked in 4 subject areas in all.
EMBO Journal is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 13.6, which places it in quartile Q1 at the 96th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 4.413, quartile Q1, with an H-index of 450.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$7,990 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
EMBO Journal is published by Springer Science and Business Media Deutschland GmbH. Its print ISSN is 0261-4189 and its online ISSN is 1460-2075.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
EMBO Journal has an h-index of 567 and a 2-year mean of 8.13 citations per paper (OpenAlex). Its Scopus CiteScore is 13.6, quartile Q1. On 2-year citations it ranks #4 of 62 Scopus journals in Immunology and Microbiology (all).
EMBO Journal published 332 papers in 2025; its busiest recent year was 2020 with 337. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (15.9%), United States (15.2%) and United Kingdom (14.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 53 retracted papers are recorded (2.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.